Csenge Advisory Group’s Baxter International BAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-5,486
Closed -$280K 602
2022
Q4
$280K Buy
5,486
+210
+4% +$11.3K 0.02% 480
2022
Q3
$284K Sell
5,276
-682
-11% -$41K 0.02% 479
2022
Q2
$383K Sell
5,958
-158
-3% -$11.5K 0.03% 387
2022
Q1
$474K Buy
6,116
+997
+19% +$83.5K 0.04% 391
2021
Q4
$417K Sell
5,119
-888
-15% -$71.5K 0.04% 378
2021
Q3
$488K Buy
6,007
+888
+17% +$70.2K 0.04% 371
2021
Q2
$417K Buy
5,119
+31
+0.6% +$2.6K 0.04% 379
2021
Q1
$432K Buy
+5,088
New +$404K 0.04% 312
2018
Q4
Sell
-143
Closed -$9K 321
2018
Q3
$9K Buy
+143
New +$10.6K ﹤0.01% 523

Other funds holding BAX

Csenge Advisory Group's BAX Position: Q1 2023 in Review

Csenge Advisory Group sold out of Baxter International (BAX) in Q1 2023, closing a stake of 5,486 shares — an estimated $280K sold.

Csenge Advisory Group first reported a position in BAX in Q3 2018 and held it in 9 quarters. The position peaked at $488K in Q3 2021. 955 funds tracked by Wall St. Rank hold BAX as of Q1 2023.

  • Csenge Advisory Group reported no remaining Baxter International position as of Q1 2023 after selling out during the quarter.
  • Csenge Advisory Group sold 5,486 Baxter International shares in Q1 2023, an estimated $280K.
  • Csenge Advisory Group first reported a position in Baxter International in Q3 2018 and held it in 9 quarters.
  • Csenge Advisory Group's Baxter International position peaked at $488K in Q3 2021.
  • 955 funds tracked by Wall St. Rank held Baxter International as of Q1 2023.

Based on Csenge Advisory Group's 13F filing for Q1 2023, filed 1 May 2023.